Abstract | OBJECTIVE: METHODS: Fifty-six patients with CTBL underwent CT before and after a 6- or 12-month course of standard chemotherapy. Three radiologists evaluated the nodal features on serial CT retrospectively, including calcification (no/punctuate/large), necrosis (no/eccentric/central), perinodal infiltrations (no/localized/extensive), and enhancing patterns (no/peripheral/homogeneous). The clinical outcome was defined as "favorable" (n = 33) or "unfavorable" (n = 23) at the completion of chemotherapy. RESULTS: All the features on the initial CT scan did not show a statistically significant difference between the favorable and unfavorable groups. On the final CT scan, absence of necrosis (P < 0.005), no infiltration (P < 0.005), no enhancement (P < 0.008), and central enhancement (P < 0.014) were more common in the favorable group, whereas large necrosis (P < 0.005), localized and extensive infiltration (P = 0.005, P < 0.005), and peripheral enhancement were more common in the unfavorable group (P < 0.005, P = 0.009). CONCLUSIONS: Central necrosis, perinodal infiltration, and peripheral rim enhancement on the final CT scan showed differences between the 2 groups. These CT features reflecting inflammation can be useful findings for assessing treatment response.
|
Authors | Bo-Kyung Je, Min Ja Kim, Sung-Bum Kim, Dae Won Park, Taik-Kun Kim, Nam Joon Lee |
Journal | Journal of computer assisted tomography
(J Comput Assist Tomogr)
2005 Nov-Dec
Vol. 29
Issue 6
Pg. 889-94
ISSN: 0363-8715 [Print] United States |
PMID | 16272869
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contrast Media
- Iohexol
- iopromide
|
Topics |
- Adult
- Aged
- Contrast Media
(administration & dosage)
- Female
- Humans
- Iohexol
(analogs & derivatives)
- Male
- Middle Aged
- Neck
(diagnostic imaging)
- Observer Variation
- Radiographic Image Enhancement
(methods)
- Time Factors
- Tomography, X-Ray Computed
(methods)
- Treatment Outcome
- Tuberculosis, Lymph Node
(diagnosis, drug therapy)
|